Cite

HARVARD Citation

    Egorova, A. et al. (2022). The first experience with sodium‐glucose cotransporter 2 inhibitor for the treatment of systemic right ventricular failure. ESC heart failure. pp. 2007-2012. [Online]. 
  
Back to record